Smartwatches track steps to predict breast cancer treatment success
NCT ID NCT07162675
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether the number of steps breast cancer patients take each day, tracked by a smartwatch, is linked to how well their treatment works. About 82 women with non-metastatic HER2-negative breast cancer will wear a Huawei Fit 2 smartwatch during chemotherapy before surgery. Researchers will compare step counts with tumor response after treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER FEMALES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Etlik City Hospital, Medical Oncology Department
RECRUITINGAnkara, Yenimahalle, 06210, Turkey (Türkiye)
-
Gazi University Medical Oncology Department
RECRUITINGAnkara, Çankaya, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Water workouts could be the key to back pain relief
- Exercise during chemo: a new weapon to preserve strength?
- Could a 7-Minute app match a gym session for fitness and sleep?
- Can online workouts bring fitness to adults with cerebral palsy?
- Can a new classification system tailor dementia care to each person?
- Ancient practice, modern question: can tai chi ease sleep problems in older adults?